Governance Classic Home
Shilpa Medicare LtdPharmaceuticalsINE790G01031Consolidated₹1020.90+63.50 (+6.63%)Jun-26
Valuation
Market Cap₹19.97K Cr
TTM PE72.16x
Forward PE58.77x
PEG2.98
Book Value₹132.49
P/B7.71x
TTM EPS₹14.15
Fwd EPS₹17.37
TTM Revenue₹1.68K Cr
TTM PAT₹297.32 Cr
TTM EBITDA₹478.55 Cr
TTM EBIT₹352.55 Cr
Last Qtr PAT₹100.88 Cr
Last Qtr EBITDA₹136.26 Cr
Last Qtr EBIT₹101.06 Cr
Profitability
ROE11.47%
ROCE12.01%
TTM NPM17.67%
TTM EBITDA %28.44%
Curr OPM21.51%
Last OPM24.57%
Curr NPM—
Last NPM—
Curr EPS₹5.16
Last EPS₹5.51
Balance sheet
Equity₹19.56 Cr
Reserve₹2.57K Cr
Total Debt₹659.97 Cr
D/E0.25x
Interest %11.99%
Curr Interest₹12.10 Cr
Price / range
Close₹1021.10
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+6.55%
1W+6.14%
1M+26.02%
3M+87.06%
6M+214.51%
1Y+149.82%
2Y+125.76%
3Y+468.70%
5Y+258.53%
Diwali+222.93%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue189.04+104.5%201.11165.70134.9392.43597.03
Other Income9.566.8911.2916.9417.7938.14
Total Income198.60+80.2%208176.99151.88110.22635.17
Interest2.532.622.742.452.2310.04
Expenditure-151.05-67.3%-158.35-151-111.39-90.26-506.46
PBDT000000
EBITDA56.01+229.7%59.793139.1416.99155.72
Depreciation-15.49-14.41-13.56-13.15-12.59-55.11
EBIT40.52+820.9%45.3817.4425.994.40100.61
PBT51.06+245.2%78.0223.7938.9214.79148.13
Tax13.86-7.05-7.85-8.105.91-15.16
Equity19.5619.5619.5609.7819.56
OPM25.7137.5113.4428.8513.4223.32
Net Profit64.92+213.6%70.9715.9330.8320.70132.97
NPM32.6934.129.0022.8518.7820.93
EPS3.32+56.6%3.630.841.582.126.80

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue597.03+25.1%477.34+54.1%309.79+25.1%247.70-30.6%356.95-57.0%830.32
Other Income38.1483.8389.1268.6440.8633.90
Total Income635.17+13.2%561.18+40.7%398.90+26.1%316.35-20.5%397.81-54.0%864.22
Expenditure-506.46-24.1%-408.20-16.5%-350.36+2.4%-359.08+5.3%-379.14+42.7%-661.63
Interest-10.04-6.60-17.26-20.83-9.05-17.47
PBDT000000
EBITDA155.72+25.0%124.60+373.8%26.30+159.8%-44-303.0%21.68-90.4%227.01
Depreciation-55.11-48.86-49.61-46.55-34.82-40.85
EBIT100.61+32.8%75.74+424.9%-23.31+74.3%-90.55-589.1%-13.14-107.1%186.16
PBT148.13+38.1%107.24+181.5%38.09+165.4%-58.28-312.0%27.49-89.2%255.54
Tax-15.16-37.43-11.158.79-7.33-71.15
Equity19.569.780000
OPM (%)23.3219.1110.00-18.007.0030.00
Net Profit132.97+90.5%69.80+159.1%26.94-52.9%57.19-59.4%140.99-23.5%184.39
NPM (%)20.9312.447.0018.0035.0021.00
EPS (Rs)6.80-5.0%7.16+131.0%3.10-53.0%6.59-60.9%16.87-25.4%22.62
CEPS6.807.163.106.5916.8722.62

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue465.78+44.9%436.99409.73369.97321.461,538.87
Other Income3.131.670.811.756.389.84
Total Income468.91+43.0%438.66410.54371.72327.841,548.71
Interest12.1013.6610.6815.6718.7858.79
Expenditure-376.82-35.8%-361.56-336.47-307.18-277.52-1,282.68
PBDT000000
EBITDA136.26+48.7%119.71114.30108.2891.64434.70
Depreciation-35.20-30.62-30.36-29.82-28.92-119.72
EBIT101.06+61.1%89.0983.9478.4662.72314.98
PBT92.09+83.0%120.4561.2164.5450.31295.31
Tax2.83-12.66-16.27-20.36-2.69-51.98
Equity19.5619.56009.7819.56
OPM19.6427.4614.9117.3615.3519.07
Net Profit100.88+115.1%107.7944.5844.0746.89243.33
NPM21.5124.5710.8611.8514.3015.71
EPS5.16+7.7%5.512.362.254.7912.44

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue1,538.87+19.6%1,286.41+11.7%1,151.60+9.7%1,050.11-8.3%1,145.52+27.1%901.13
Other Income9.8423.158.1717.4014.2530.14
Total Income1,548.71+18.3%1,309.57+12.9%1,159.77+8.6%1,067.51-8.0%1,159.77+24.5%931.27
Expenditure-1,282.68-10.8%-1,157.89-4.6%-1,106.79-0.4%-1,101.98-3.7%-1,062.63-33.6%-795.32
Interest-58.79-75.53-91.81-58.65-41.17-21.87
PBDT000000
EBITDA434.70+37.1%317.04+29.7%244.49+139.0%102.28-49.8%203.86+12.2%181.66
Depreciation-119.72-112.99-107.87-95.50-79.80-53.98
EBIT314.98+54.4%204.05+49.4%136.62+1915.0%6.78-94.5%124.06-2.8%127.68
PBT295.31+138.9%123.59+109.0%59.12+271.5%-34.47-133.7%102.27-48.0%196.79
Tax-51.98-44.04-22.397.36-41.68-48.85
Equity19.569.780000
OPM (%)19.079.445.10-3.238.8221.13
Net Profit243.33+210.8%78.29+145.7%31.87+198.1%-32.48-153.5%60.66-58.5%146.20
NPM (%)15.715.982.75-3.045.2315.70
EPS (Rs)12.44+54.7%8.04+119.1%3.67-1.9%3.74-48.5%7.26-60.0%18.13
CEPS12.448.043.673.747.2618.13

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

17
YearTypeAmountEx-Date
2026Final Dividend0.604 Sep 2026
2025Final Dividend117 Sep 2025
2022Final Dividend1.119 Sep 2022
2021Final Dividend1.120 Sep 2021
2020Interim Dividend1.116 Mar 2020
2019Final Dividend112 Sep 2019
2018Interim Dividend0.701 Mar 2018
2017Interim Dividend0.621 Mar 2017
2016Interim Dividend0.628 Mar 2016
2015Final Dividend1.116 Sep 2015
2014Final Dividend111 Sep 2014
2013Final Dividend1.316 Jul 2013
2012Final Dividend0.917 Sep 2012
2011Final Dividend0.815 Sep 2011
2010Final Dividend0.716 Sep 2010
2009Final Dividend0.524 Sep 2009
2008Final Dividend0.411 Sep 2008

Bonus

2
YearRatioEx-Date
20251:103 Oct 2025
20131:216 Jul 2013

Split

1
YearRatioEx-Date
2015Rs.2/- to Rs.1/-06 Nov 2015
Loading company dashboard...
Fetching ratios, charts, and peers